Mitochondrial Control Region Variants Related to Breast Cancer

• Published in: Genes Vol. 13; no. 11; p. 1962
• Main Authors: Vega Avalos, Jorge Hermilo, Hernández, Luis Enrique, Zuñiga, Laura Yareni, Sánchez-Parada, María Guadalupe, González Santiago, Ana Elizabeth, Román Pintos, Luis Miguel, Castañeda Arellano, Rolando, Hernández-Ortega, Luis Daniel, Mercado-Sesma, Arieh Roldán, Orozco-Luna, Felipe de Jesús, Baptista-Rosas, Raúl C
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 27-10-2022; MDPI
• Subjects: Biomarkers; Breast cancer; Cancer; Carcinogenesis; Disease; Genetic aspects; Genomes; Health aspects; Medical diagnosis; Mitochondria; Mitochondrial DNA; Mutation; Phylogenetics; Physiological aspects; Polymorphism; Population; Statistical analysis; Womens health; Mexico
• ISSN: 2073-4425; 2073-4425
• DOI: 10.3390/genes13111962

Breast cancer has an important incidence in the worldwide female population. Although alterations in the mitochondrial genome probably play an important role in carcinogenesis, the actual evidence is ambiguous and inconclusive. Our purpose was to explore differences in mitochondrial sequences of cases with breast cancer compared with control samples from different origins. We identified 124 mtDNA sequences associated with breast cancer cases, of which 86 were complete and 38 were partial sequences. Of these 86 complete sequences, 52 belonged to patients with a confirmed diagnosis of breast cancer, and 34 sequences were obtained from healthy mammary tissue of the same patients used as controls. From the mtDNA analysis, two polymorphisms with significant statistical differences were found: m.310del (rs869289246) in 34.6% (27/78) of breast cancer cases and 61.7% (21/34) in the controls; and m.315dup (rs369786048) in 60.2% (47/78) of breast cancer cases and 38.2% (13/34) in the controls. In addition, the variant m.16519T>C (rs3937033) was found in 59% of the control sequences and 52% of the breast cancer sequences with a significant statistical difference. Polymorphic changes are evolutionarily related to the haplogroup H of Indo-European and Euro-Asiatic origins; however, they were found in all non-European breast cancers.